Benzinga | Jun 18, 2021 09:47AM EDT

Sanofi Shares On Watch; European Commission Approves Aubagoi As First Oral MS Therapy For First-Line Treatment Of Children And Adolescents Living With Relapsing-Remitting Multiple Sclerosis

-Reuters